anti-TNFRSF25 (TNFRSF25) Antikörper

anti-Tumor Necrosis Factor Receptor Superfamily, Member 25 Antikörper (TNFRSF25)
Auf finden Sie aktuell 221 Tumor Necrosis Factor Receptor Superfamily, Member 25 (TNFRSF25) Antikörper von 30 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen TNFRSF25 Proteine (14) und TNFRSF25 Kits (5) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 255 TNFRSF25 Produkte verfügbar.
APO-3, DDR3, DR3, LARD, Tnfrsf12, TNFRSF25, TR3, TRAMP, Wsl, WSL-1, WSL-LR
Alle Antikörper anzeigen Gen GeneID UniProt
TNFRSF25 8718 Q93038
TNFRSF25 85030  
TNFRSF25 500592  

Alle Spezies anzeigen

Weitere Synonyme anzeigen

Meistgesuchte Reaktivitäten zu anti-TNFRSF25 (TNFRSF25) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Human TNFRSF25 Antikörper:

anti-Mouse (Murine) TNFRSF25 Antikörper:

anti-Rat (Rattus) TNFRSF25 Antikörper:

Alle verfügbaren anti-TNFRSF25 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-TNFRSF25 Antikörper

  1. Human Monoclonal TNFRSF25 Primary Antibody für ELISA - ABIN610236 : Crews, Alessandrini, Erikson: The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. in Science (New York, N.Y.) 1992 (PubMed)
    Zeige alle 3 Referenzen für 610236

  2. Human Polyclonal TNFRSF25 Primary Antibody für WB - ABIN2473362 : Chinnaiyan, ORourke, Yu, Lyons, Garg, Duan, Xing, Gentz, Ni, Dixit: Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. in Science (New York, N.Y.) 1996 (PubMed)
    Zeige alle 2 Referenzen für 2473362

  3. Human Monoclonal TNFRSF25 Primary Antibody für FACS, WB - ABIN4900568 : Porquet, Poirier, Houle, Pin, Gout, Tremblay, Paquet, Klinck, Auger, Huot: Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3. in BMC cancer 2011 (PubMed)
    Zeige alle 2 Referenzen für 4900568

  4. Human Polyclonal TNFRSF25 Primary Antibody für IF (p), IHC (p) - ABIN668421 : ?lebioda, Bojarska-Junak, Stanis?awowski, Cyman, Wierzbicki, Roli?ski, Celi?ski, Kmie?: TL1A as a potential local inducer of IL17A Expression in colon mucosa of inflammatory bowel disease patients. in Scandinavian journal of immunology 2015 (PubMed)

  5. Cow (Bovine) Polyclonal TNFRSF25 Primary Antibody für WB - ABIN2792146 : Borysenko, García-Palacios, Griswold, Li, Iyer, Yaroslavskiy, Sharrow, Blair: Death receptor-3 mediates apoptosis in human osteoblasts under narrowly regulated conditions. in Journal of cellular physiology 2006 (PubMed)

  6. Human Monoclonal TNFRSF25 Primary Antibody für FACS - ABIN262780 : Cavallini, Lovato, Bertolaso, Zoratti, Malpeli, Mimiola, Tinelli, Aprili, Tecchio, Perbellini, Scarpa, Zamò, Cassatella, Pizzolo, Scupoli: Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia. in Oncotarget 2015 (PubMed)

Weitere Antikörper gegen TNFRSF25 Interaktionspartner

Human Tumor Necrosis Factor Receptor Superfamily, Member 25 (TNFRSF25) Interaktionspartner

  1. In addition to apoptosis, DR3 can robustly trigger necroptotic cell death and provide evidence for TL1A (zeige TNFSF15 Antikörper)-induced, DR3-mediated necrosome assembly. DR3-mediated necroptosis critically depends on receptor-interacting protein 1 (RIP1 (zeige RIPK1 Antikörper)) and RIP3 (zeige RIPK3 Antikörper), the core components of the necroptotic machinery, which activate the pseudo-kinase mixed lineage kinase domain-like, the prototypic downstream effector molecule of necroptosis.

  2. Data suggest that human regulatory T-lymphocytes express DR3 and demonstrate DR3/TL1A (zeige TNFSF15 Antikörper)-mediated activation of signaling via MAP kinases and NFkappaB (zeige NFKB1 Antikörper). (DR3 = death receptor 3; TL1A/TNFSF15 (zeige TNFSF15 Antikörper) = tumor necrosis factor (zeige TNF Antikörper) [ligand] superfamily, member 15)

  3. These results raise the possibility for involvement of TL1A (zeige TNFSF15 Antikörper)/DR3/DR3-mediated mechanisms in epithelial-mesenchymal interactions and the development of inflammation-induced intestinal fibrosis in Crohn's disease.

  4. Activation of DR3 is accompanied by inhibition of apoptosis of naive T-lymphocytes in children with acute infectious mononucleosis.

  5. Biologics beyond TNF-alpha (zeige TNF Antikörper) inhibitors and the effect of targeting the homologues TL1A (zeige TNFSF15 Antikörper)-DR3 pathway in chronic inflammatory disorders.

  6. Higher DR3 levels were associated with early stage chronic lymphocytic leukemia.

  7. DR3 is efficiently activated by soluble TL1A (zeige TNFSF15 Antikörper) trimers.

  8. These data identify new roles for DR3 in regulating OB-dependent bone mineral apposition.

  9. Human memory IL-18Ralpha and DR3 CD4 (zeige CD4 Antikörper)+ T cells may contribute to antigen-independent innate responses at barrier surfaces.

  10. DR3 is expressed by IL-22 (zeige IL22 Antikörper)-producing human group 3 innate lymphoid cells (ILC3s).

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 25 (TNFRSF25) Interaktionspartner

  1. This work describes both a novel function and essential requirement for the DR3/TL1A (zeige TNFSF15 Antikörper) pathway in acute, resolving, and chronic inflammation in the peritoneal cavity.

  2. this study shows that DR3 signaling protects mice from acute dextran sodium sulfate colitis because DR3-/- mice showed more severe mucosal inflammation and increased mortality

  3. the critical effect of the state of T-cell activation on clinical outcomes after activation of DR3, is reported.

  4. These data identify new roles for DR3 in regulating OB-dependent bone mineral apposition.

  5. Data indicate that death receptor 3 (DR3) depletion gives rise to an increased anti-apoptotic potential.

  6. these data identify TL1A (zeige TNFSF15 Antikörper)-DR3 interactions as a novel pathway that promotes Th9 differentiation and pathogenicity. TL1A (zeige TNFSF15 Antikörper) may be a potential therapeutic target in diseases dependent on IL-9 (zeige IL9 Antikörper).

  7. TL1A (zeige TNFSF15 Antikörper) induces NF-kappaB (zeige NFKB1 Antikörper) activation in EC in renal and cardiac tissue from wild type but not DR3 knock-out mice.

  8. Both in supernatant and as purified fusion protein, TL1A (zeige TNFSF15 Antikörper)-Ig binds to TNFRSF25 transfected--but not untransfected--P815 tumor cells as determined by flow cytometry.

  9. TNFRSF25 agonists expand Tregs in vivo and delay cardiac allograft rejection.

  10. TNFRSF25 agonistic antibody and galectin-9 (zeige LGALS9 Antikörper) combination therapy controls herpes simplex virus-induced immunoinflammatory lesions

TNFRSF25 Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed preferentially in the tissues enriched in lymphocytes, and it may play a role in regulating lymphocyte homeostasis. This receptor has been shown to stimulate NF-kappa B activity and regulate cell apoptosis. The signal transduction of this receptor is mediated by various death domain containing adaptor proteins. Knockout studies in mice suggested the role of this gene in the removal of self-reactive T cells in the thymus. Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported, most of which are potentially secreted molecules. The alternative splicing of this gene in B and T cells encounters a programmed change upon T-cell activation, which predominantly produces full-length, membrane bound isoforms, and is thought to be involved in controlling lymphocyte proliferation induced by T-cell activation.

Alternative names and synonyms associated with TNFRSF25

  • tumor necrosis factor receptor superfamily, member 25 (TNFRSF25) Antikörper
  • tumor necrosis factor receptor superfamily, member 25 (Tnfrsf25) Antikörper
  • APO-3 Antikörper
  • DDR3 Antikörper
  • DR3 Antikörper
  • LARD Antikörper
  • Tnfrsf12 Antikörper
  • TNFRSF25 Antikörper
  • TR3 Antikörper
  • TRAMP Antikörper
  • Wsl Antikörper
  • WSL-1 Antikörper
  • WSL-LR Antikörper

Bezeichner auf Proteinebene für TNFRSF25

tumor necrosis factor receptor superfamily, member 25 , apoptosis inducing receptor , apoptosis-inducing receptor AIR , apoptosis-mediating receptor DR3 , apoptosis-mediating receptor TRAMP , death domain receptor 3 soluble form , death receptor beta , lymphocyte-associated receptor of death , protein WSL-1 , tumor necrosis factor receptor superfamily member 25 , tumor necrosis factor receptor superfamily, member 12 (translocating chain-association membrane protein) , tumor necrosis factor receptor superfamily, member 12 , translocating chain-association membrane protein , tumor necrosis factor receptor superfamily, member12

489632 Canis lupus familiaris
703744 Macaca mulatta
749145 Pan troglodytes
100594987 Nomascus leucogenys
8718 Homo sapiens
85030 Mus musculus
783432 Bos taurus
500592 Rattus norvegicus
Ausgewählte Anbieter für anti-TNFRSF25 (TNFRSF25) Antikörper
Haben Sie etwas anderes gesucht?